Traws Pharma Establishes $50 Million Stock Purchase Facility
Traws Pharma may sell up to $50 million of newly issued shares over 36 months, subject to specified conditions.
Traws Pharma may sell up to $50 million of newly issued shares over 36 months, subject to specified conditions.